Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of HPV Vaccine in HIV-infected Individuals
NCT07797894Phase 2Not yet recruiting
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Sep 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of Cecolin 9 in human papillomavirus infection, sponsored by The Fifth Medical Center of the PLA General Hospital. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Cecolin 9
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT07797894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07797894.